Results 81 to 90 of about 3,798 (162)

Efektivitas dan Keamanan Terlipressin pada Acute Variceal Haemorhage: Sebuah Kajian Naratif

, 2020
Providing appropriate yet timely treatment to stop bleeding is the key pathway in the management of acute variceal haemorhage (AVH). Several agents can be used to manage bleeding, and one of the new agent recently approved in Indonesia in 2019 is ...
Setiawan, Eko, Halim, Steven Victoria
core   +1 more source

Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs

, 1999
BACKGROUND/AIMS: Terlipressin is used for the treatment of bleeding oesophageal varices. We evaluated the effects of terlipressin on hepatic haemodynamics, with special focus on the interactions between portal venous flow and hepatic arterial flow over ...
Hansen, EF, Henriksen, Jens Henrik Sahl, Højgaard, L, Strandberg, C, Becker, U, Schroeder, T V, Bendtsen, F, Madsen, J   +7 more
core   +1 more source

Hepatorenal Sendromlu Bir Hastada Terlipressin Tedavisine İkincil Skrotal Nekroz

, 2019
Hepatorenal syndrome is a reversible acute renal impairment that occurs in patients with advanced liver cirrhosis or fulminant hepatic failure. Terlipressin is a synthetic long-acting analogue of vasopressin that is used in the treatment of hepatorenal ...
Soysal, Dilek Ersil, Karakuş, Volkan
core  

Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension

Annals of Cardiac Anaesthesia, 2019
Introduction: Milrinone at inotropic doses requires the addition of a vasoconstrictive drug. We hypothesized that terlipressin use could selectively recover the systemic vascular hypotension induced by milrinone without increasing the pulmonary vascular ...
Mai Mohsen Abdelazziz, Hadil Magdi Abdelhamid   +1 more
doaj   +1 more source

Terlipressin infusion in catecholamine-resistant shock.

, 2003
Catecholamine-resistant shock is not uncommon in intensive care. Bolus dose terlipressin (a vasopressin analogue) has been used successfully in this setting allowing cessation of other vasopressor agents.
Stephens, D P, Jolley, D H, De Keulenaer, B L, Potter, A   +3 more
core  

Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis

, 2010
Udgivelsesdato: 2010-May-5BACKGROUND: The vasoconstrictor terlipressin is widely used in the treatment of the hepatorenal syndrome and variceal bleeding. However, terlipressin may compromise cardiac function and induce ischemia.
Mortensen, Christian, Møller, Søren, Henriksen, Jens H, Krag, Aleksander, Bendtsen, Flemming   +4 more
core   +1 more source

USING TERLIPRESSIN AIMED TO REDUCE BLOOD LOSS IN CESAREAN SECTION [PDF]

, 2019
The objective of the study: to assess the impact of the agonist of vasopressin receptor V-1 (terlipressin) in the operative delivery of obstetric patients with a high risk of hemorrhage during cesarean section.Subjects and methods. 60 women were examined,
Yu. S. Аleksandrovich, E. S. Kononova, O. V. Ryazanova, A. V. Rostovtsev, T. I. Аkimenko   +4 more
core   +1 more source

TERLIPRESSIN VERSUS NORADRENALINE FOR HEPATORENAL SYNDROME. Economic evaluation under the perspective of the Brazilian Public Health System

Arquivos de Gastroenterologia
Background - Terlipressin and noradrenaline are the best studied treatments for hepatorenal syndrome, and there is no evidence of superiority of one over the other regarding to efficacy.
Ângelo Zambam de MATTOS, Angelo Alves de MATTOS, Rodrigo Antonini RIBEIRO   +2 more
doaj   +1 more source

Evaluation of patients after treatment with terlipressin [PDF]

, 2013
Introdução: Sangramento de varizes esofágicas e síndrome hepatorrenal são complicações com altas taxas de morbidade e são comuns em pacientes cirróticos.
Bueno, Denise, Carrasco, Rafael Dornelles, Gioda, Ricardo Soares, Sampaio, Gabriella Calvi   +3 more
core   +1 more source

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.

PLoS ONE
The treatment of choice for hepatorenal syndrome-acute kidney injury (HRS-AKI) is vasoconstrictor therapy in combination with albumin, preferably norepinephrine or terlipressin as recommended by recent guidelines.
Jody C Olson, Ram M Subramanian
doaj   +1 more source